Bringing the fundamentals into focus…
Back to Ovid Therapeutics Inc.
How Ovid Therapeutics Inc. stacks up
OVID · against 394 other Healthcare companies of similar size
Growth
76/ 100
Near the top of its peers.
Ranked #81 of 395 · scores higher than 79% of peers
Bars: peers in each 10-point band of the growth score40 peers with a growth score of 70–79, including OVID · Click a bar to see the companies
Why growth scores 76?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
- slower revenue growth over the last year: weaker than 98% of peers. Revenue growth: -76.2% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 96% of peers. 3-year revenue growth: 99.8% vs peer median 5.8%
Metric by metric
Position: dot = OVID, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | OVID | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 409 reported | -76.2% | 3.0% | 2% | 33% | |
| Earnings per share growthHigher is better · 201 reported | Not reported | 3.6% | — | — | 33% |
| 3-year revenue growthHigher is better · 387 reported | 99.8% | 3.7% | 96% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around OVID| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 76 | 468M EUR (≈$514M) | 77 | 57 | |
| 76 | 5.5B NOK (≈$523M) | 77 | 71 | |
| 81 | 748M USD | 76 | 62 | |
| 81 | 1.1B CAD (≈$807M) | 76 | 60 | |
| 81 | 469M USD | 76 | 45 | |
| 81 | 660M GBP (≈$858M) | 76 | 35 | |
| 81 | 360M USD | 76 | 67 | |
| 86 | 4.0B CNY (≈$554M) | 75 | 71 | |
| 86 | 749M USD | 75 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score